Highlights InhaleRx Limited

Equities

IRX

AU0000179475

Market Closed - Australian S.E. Other stock markets 08:25:33 2024-05-01 pm EDT			5-day change	1st Jan Change
0.039 ^AUD	+21.88%		+39.29%	+34.48%

Mar. 28	InhaleRx Limited announced that it expects to receive AUD 0.5 million in funding from Peak Asset Management, LLC	CI
Feb. 14	InhaleRx Limited Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

InhaleRx Limited Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 13	CI
InhaleRx Files Ethics Application for Panic Disorder Trial	23-10-17	MT
InhaleRx Limited Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-21	CI
InhaleRx Doses First Individuals for Phase One Trial of Inhalable Pain Medication	23-06-07	MT
InhaleRx Limited Reports Earnings Results for the Full Year Ended December 31, 2022	23-02-26	CI
InhaleRx Hires Contract Research Organization for Upcoming Clinical Trials	22-12-22	MT
Inhalerx Limited Announces Fda Pre-Ind Application Update	22-12-11	CI
InhaleRx Limited Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-31	CI
InhaleRx Secures Licenses to Sell, Supply Controlled Substances	22-03-30	MT
InhaleRx Limited Reports Earnings Results for the Full Year Ended December 31, 2021	22-02-27	CI
Lifespot Health Ltd Reports Earnings Results for the Half Year Ended June 30, 2021	21-08-31	CI
Lifespot Health Ltd Reports Earnings Results for the Full Year Ended December 31, 2020	21-02-25	CI
Lifespot Health Ltd Reports Earnings Results for the Half Year Ended June 30, 2020	20-08-28	CI
Lifespot Health Ltd Announces Fevertel Medical Device TGA Registration	20-06-24	CI
Jayex Healthcare Signs Licence Agreement to Sell Lifespot Health's Existing and Future Telehealth Products	20-06-10	CI
Lifespot Health Limited to Further Develop and Complete the Bodyteltm App and Platform Extension to Incorporate Temperature Monitoring	20-03-24	CI
Lifespot Health Ltd Reports Earnings Results for the Full Year Ended December 31, 2019	20-02-28	CI
Lifespot Health Ltd Updates on Development of Medical Cannabis Vaporiser and App	19-12-05	CI
Lifespot Health Ltd Reports Earnings Results for the Half Year Ended June 30, 2019	19-08-30	CI
IONIC Brands Corp. Signs Heads of Agreement With Lifespot Health Limited to Develop and Distribute Lifespot’s Software and Vaporizer Technologies	19-07-02	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights InhaleRx Limited

Equities

IRX

AU0000179475

Highlights

Filters